Clinical trials
Recruiting Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tongji Hospital | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Beijing Tiantan Hospital | 1 |
| Cedars-Sinai Medical Center | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Hospices Civils de Lyon | 1 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 1 |
| Third Affiliated Hospital, Sun Yat-Sen University | 1 |
| University of Bern | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 12 |
| Neuromyelitis Optica | 11 |
| Multiple Sclerosis | 10 |
| Autoimmune Diseases of the Nervous System | 4 |
| Encephalomyelitis, Acute Disseminated | 3 |
| Myasthenia Gravis | 2 |
| Optic Neuritis | 2 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.